Substituted Cyanopyridines as protein kinase inhibitors
申请人:Cole Derek Cecil
公开号:US20070287738A1
公开(公告)日:2007-12-13
The present teachings provide compounds of formula I
and their pharmaceutically acceptable salts, hydrates, and esters, wherein R
1
, R
2
, and X are as defined herein. The present teachings also provide methods of making the compounds of formula I, and methods of treating autoimmune and inflammatory diseases by administering a therapeutically effective amount of a compound or compounds of formula I to a mammal including a human.
A series of 5-vinyl-3-pyridinecarbonitriles were synthesized and evaluated as PKC theta inhibitors. The systematic optimization of 4-[(4-methyl-1H-indol-5-yl)amino]-5-[(E)-2-phenylvinyl]-3-pyridinecarbonitrile 3 resulted in the identification of compound 23e as a potent PKC theta inhibitor with good selectivity over PKC delta. (C) 2009 Elsevier Ltd. All rights reserved.
SUBSTITUTED CYANOPYRIDINES AS PROTEIN KINASE INHIBITORS
申请人:Wyeth
公开号:EP2027093A2
公开(公告)日:2009-02-25
SUBSTITUTED 3-CYANOPYRIDINES AS PROTEIN KINASE INHIBITORS